Copyright
©The Author(s) 2023.
World J Gastroenterol. Jun 7, 2023; 29(21): 3362-3378
Published online Jun 7, 2023. doi: 10.3748/wjg.v29.i21.3362
Published online Jun 7, 2023. doi: 10.3748/wjg.v29.i21.3362
Figure 4 Forest plot for hospital length of stay in coronavirus disease 2019 patients.
A: In coronavirus disease 2019 (COVID-19) patients with and without non-alcoholic fatty liver disease/metabolic-associated fatty liver disease (NAFLD/MAFLD); B: In COVID-19 patients with and without NAFLD/MAFLD sensitivity analysis after excluding Madan et al[41]. CI: Confidence interval.
- Citation: Jagirdhar GSK, Qasba RK, Pattnaik H, Rama K, Banga A, Reddy ST, Flumignan Bucharles AC, Kashyap R, Elmati PR, Bansal V, Bains Y, DaCosta T, Surani S. Association of non-alcoholic fatty liver and metabolic-associated fatty liver with COVID-19 outcomes: A systematic review and meta-analysis. World J Gastroenterol 2023; 29(21): 3362-3378
- URL: https://www.wjgnet.com/1007-9327/full/v29/i21/3362.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i21.3362